text.skipToContent text.skipToNavigation

Sartorius Stedim Biotech Investor Relations


First-Half Financial Report from January to June 2019

The Sartorius Stedim Biotech Group will publish its half-year 2019 results on July 19, 2019, at 7 a.m. CEST. Dr. Joachim Kreuzburg, CEO, will discuss the results with analysts and investors at 3.30 p.m. CEST.

To register for the teleconference, please use the following link: http://services.choruscall.de/DiamondPassRegistration/register?confirmationNumber=1777335&linkSecurityString=1127bde29


Alternatively, you can dial into the teleconference, without registering, at:

+49 (0) 69 566 03 6000


The presentation will be accessible through our website that day, 3.15 p.m. CEST, at: https://www.sartorius.com/en/company/investor-relations/sartorius-stedim-biotech-sa-investor-relations

Half-Year Report H1 2019

Press Release H1 2019

Excel File

Conference Call H1 2019 Presentation

Facts & Figures

Download a brief overview of Sartorius Stedim Biotech and its current economic development.

Fact Sheet H1 2019


Three-Month 2019 Results

Annual Report 2018


Preliminary Results January to December 2018

Nine-month Results January to September 2018

Half-Year 2018 Results

First-Quarter 2018 Results

Annual Report 2017

Sartorius Capital Markets Day 2018